362 related articles for article (PubMed ID: 16258654)
1. Guillain-Barré syndrome in the elderly: clinical, electrophysiological, therapeutic and outcome features.
França MC; Deus-Silva L; de Castro R; Garibaldi SG; Pfeilsticker BH; Nucci A; Marques JF
Arq Neuropsiquiatr; 2005 Sep; 63(3B):772-5. PubMed ID: 16258654
[TBL] [Abstract][Full Text] [Related]
2. [Guillain-Barré syndrome in childhood].
Kollár K; Liptai Z; Rosdy B; Móser J
Ideggyogy Sz; 2009 Nov; 62(11-12):399-404. PubMed ID: 20025130
[TBL] [Abstract][Full Text] [Related]
3. Guillain-Barre syndrome: a clinical study in King Chulalongkorn Memorial Hospital.
Areeyapinan P; Phanthumchinda K
J Med Assoc Thai; 2010 Oct; 93(10):1150-5. PubMed ID: 20973317
[TBL] [Abstract][Full Text] [Related]
4. Long-term prognosis for Guillain-Barré syndrome: evaluation of prognostic factors and clinical experience of automated double filtration plasmapheresis.
Cheng BC; Chang WN; Chen JB; Chee EC; Huang CR; Lu CH; Chang CJ; Hung PL; Chuang YC; Lee CT; Lee PY; Wang KW; Chang HW
J Clin Apher; 2003; 18(4):175-80. PubMed ID: 14699593
[TBL] [Abstract][Full Text] [Related]
5. Plasmapheresis treatment in Guillain-Barré syndrome: potential benefit over IVIg in patients with axonal involvement.
Dada MA; Kaplan AA
Ther Apher Dial; 2004 Oct; 8(5):409-12. PubMed ID: 15663537
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological, clinical and epidemiological study of Guillain-Barre Syndrome in Hong Kong Chinese.
Hui AC; Chow KM; Tang AS; Fu M; Kay R; Wong KS
J Clin Neurosci; 2005 Feb; 12(2):134-6. PubMed ID: 15749412
[TBL] [Abstract][Full Text] [Related]
7. Use of immunoglobulin in severe childhood Guillain-Barré syndrome.
Ortiz-Corredor F; Peña-Preciado M
Acta Neurol Scand; 2007 Apr; 115(4):289-93. PubMed ID: 17376129
[TBL] [Abstract][Full Text] [Related]
8. Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS).
Verma R; Chaudhari TS; Raut TP; Garg RK
J Neurol Sci; 2013 Dec; 335(1-2):105-11. PubMed ID: 24064258
[TBL] [Abstract][Full Text] [Related]
9. Clinical variants of Guillain-Barre syndrome: some aspects of differential diagnosis.
Dididze MN
Georgian Med News; 2009 Jan; (166):48-51. PubMed ID: 19202218
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome.
Kuitwaard K; de Gelder J; Tio-Gillen AP; Hop WC; van Gelder T; van Toorenenbergen AW; van Doorn PA; Jacobs BC
Ann Neurol; 2009 Nov; 66(5):597-603. PubMed ID: 19938102
[TBL] [Abstract][Full Text] [Related]
11. Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barré syndrome: critical reassessment of effectiveness and cost-efficiency.
Oczko-Walker M; Manousakis G; Wang S; Malter JS; Waclawik AJ
J Clin Neuromuscul Dis; 2010 Dec; 12(2):55-61. PubMed ID: 21386771
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentation and prognosis of childhood Guillain-Barré syndrome.
Lee JH; Sung IY; Rew IS
J Paediatr Child Health; 2008; 44(7-8):449-54. PubMed ID: 18557809
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing outcome in Guillain-Barré Syndrome: comparison of plasma adsorption against other treatments.
Seta T; Nagayama H; Katsura K; Hamamoto M; Araki T; Yokochi M; Utsumi K; Katayama Y
Clin Neurol Neurosurg; 2005 Oct; 107(6):491-6. PubMed ID: 16202823
[TBL] [Abstract][Full Text] [Related]
14. Mechanical ventilation in Guillain-Barré syndrome: does age influence functional outcome?
Köhrmann M; Huttner HB; Nowe T; Schellinger PD; Schwab S
Eur Neurol; 2009; 61(6):358-63. PubMed ID: 19365128
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M
Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
[TBL] [Abstract][Full Text] [Related]
16. [Guillain-Barre syndrome and its frontiers].
Azulay JP; Verschueren A; Attarian S; Pouget J
Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S21-6. PubMed ID: 12690657
[TBL] [Abstract][Full Text] [Related]
17. [The effect of plasmapheresis and other immunomodulating therapies on the course of severe Guillain-Barré syndrome].
Hidasi E; Soltész P
Orv Hetil; 2001 Feb; 142(7):335-9. PubMed ID: 11243015
[TBL] [Abstract][Full Text] [Related]
18. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
Pascual-Pascual SI
Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
[TBL] [Abstract][Full Text] [Related]
19. Association between acute motor axonal neuropathy and ophthalmoplegia during pregnancy.
Yerdelen D; Kucukgoz U; Karatas M
J Clin Neurosci; 2011 Jul; 18(7):999-1000. PubMed ID: 21565505
[TBL] [Abstract][Full Text] [Related]
20. Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome.
Okamiya S; Ogino M; Ogino Y; Irie S; Kanazawa N; Saito T; Sakai F
Ther Apher Dial; 2004 Jun; 8(3):248-53. PubMed ID: 15154879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
